Outcomes with Pre-Emptive Rituximab (pre-R) Treatment for Epstein-Barr Viremia (EBV) after Allogeneic Hematopoietic Stem Cell Transplantation (HCT)

被引：2
|
作者：
Jain, Tania
Kung, Shu Ting
Kosiorek, Heidi
Shah, Vishal
Khera, Nandita
Leis, Jose
Noel, Pierre
Palmer, Jeanne
Slack, James L.
Sproat, Lisa Z.
机构：
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2017年 / 23卷 / 03期
关键词：
D O I：
10.1016/j.bbmt.2016.12.187
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
382
引用
收藏
页码：S279 / S280
页数：2
相关论文
共 50 条
  • [1] Pre-emptive rituximab for Epstein-Barr virus reactivation after haplo-hematopoietic stem cell transplantation
    Kobayashi, Shogo
    Sano, Hideki
    Mochizuki, Kazuhiro
    Ohara, Yoshihiro
    Takahashi, Nobuhisa
    Ohto, Hitoshi
    Kikuta, Atsushi
    PEDIATRICS INTERNATIONAL, 2017, 59 (09) : 973 - 978
  • [2] Pre-Emptive Rituximab Treatment for Epstein-Barr Virus (EBV) Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): High Incidence of Infections and Delayed Immune Reconstitution
    Petropoulou, Anna D.
    Porcher, Raphael
    de Latour, Regis Peffault
    Xhaard, Alienor
    Ribaud, Patricia
    Socie, Gerard
    Robin, Marie
    BLOOD, 2010, 116 (21) : 950 - 951
  • [3] Impact of Pre-Emptive Rituximab Treatment for Epstein-Barr Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Longitudinal Study of 110 Patients
    Stocker, Nicolas
    Labopin, Myriam
    Boussen, Ines
    Lamarthee, Baptiste
    Malard, Florent
    Bonnin, Agnes
    Marechal, Vincent
    Amiel, Corinne
    Quignon, Frederique
    Gozlan, Joel
    Battipaglia, Giorgia
    Dulery, Remy
    Giannotti, Federica
    Ruggeri, Annalisa
    Gaugler, Beatrice
    Mohty, Mohamad
    Brissot, Eolia
    BLOOD, 2017, 130
  • [4] Pre-emptive treatment with rituximab for Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation: a safety and efficacy study
    Ganguly, S.
    DuBois, L.
    Divine, C.
    Aljitawi, O.
    Abhyankar, S.
    McGuirk, J.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S225 - S225
  • [5] Increased infection rate after pre-emptive rituximab treatment for Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation
    Petropoulou, A.
    Porcher, R.
    de Latour, R. Peffault
    Xhaard, A.
    Ribaud, P.
    Rodriguez-Otero, P.
    Toubert, A.
    Carmagnat, M.
    Socie, G.
    Robin, M.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S80 - S81
  • [6] Pre-emptive therapy with rituximab for prevention of Epstein-Barr virus-associated lymphoproliferative disease after hematopoietic stem cell transplantation
    Gruhn, B
    Meerbach, A
    Häfer, R
    Zell, R
    Wutzler, P
    Zintl, F
    BONE MARROW TRANSPLANTATION, 2003, 31 (11) : 1023 - 1025
  • [7] Use of Rituximab As a Pre-Emptive Therapy for Epstein-Barr Virus (EBV)-Associated Lymphoproliferative Disorders in 86 Adult Patients Having Allogeneic Stem Cell Transplantation
    Auger, Sophie
    Orsini, Mattea
    Fegueux, Nathalie
    Ceballos, Patrice
    Mines, Marie Luce
    Rossi, Jean-Francois
    BLOOD, 2011, 118 (21) : 871 - 871
  • [8] Pre-Emptive Rituximab Use for Epstein-Barr Virus (EBV) Viremia in Cardiothoracic Solid Organ Transplant Recipients.
    Astorga, B.
    Loethen, A.
    Potter, L.
    Patel, S.
    Plews, R.
    Conti, D.
    Ortiz, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 784 - 784
  • [9] Lymphoproliferative disease after allogeneic stem cell transplantation - pre-emptive diagnosis by quantification of Epstein-Barr virus DNA in serum
    Aalto, SM
    Juvonen, E
    Tarkkanen, J
    Volin, L
    Ruutu, T
    Mattila, PS
    Piiparinen, H
    Knuutila, S
    Hedman, K
    JOURNAL OF CLINICAL VIROLOGY, 2003, 28 (03) : 275 - 283
  • [10] Pre-emptive rituximab treatment for Epstein-Barr virus reactivation after allogeneic hematopoietic stem cell transplantation is a worthwhile strategy in high-risk recipients: a comparative study for immune recovery and clinical outcomes
    Stocker, Nicolas
    Labopin, Myriam
    Boussen, Ines
    Paccoud, Olivier
    Bonnin, Agnes
    Malard, Florent
    Amiel, Corinne
    Gozlan, Joel
    Battipaglia, Giorgia
    Dulery, Remy
    Giannotti, Federica
    Ruggeri, Annalisa
    Gaugler, Beatrice
    Mohty, Mohamad
    Brissot, Eolia
    BONE MARROW TRANSPLANTATION, 2020, 55 (03) : 586 - 594
12345